Healthcare -
Biotechnology - NASDAQ - US
$ 4.07
-2.63 %
$ 141 M
Market Cap
-4.33
P/E
GNLX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss GNLX - Genelux Corporation
14 K
LAST VALUE
164.58%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR